JCR Pharmaceuticals Co., Ltd. (4552.T)

JPY 610.0

(-0.81%)

Annual Balance Sheets

(In JPY)
Breakdown 2024 2023 2022 2021 2020 2019
Total Assets 102.22 Billion 94.93 Billion 97.13 Billion 73.78 Billion 47.77 Billion 42.51 Billion
Total Current Assets 57.58 Billion 47.8 Billion 62.18 Billion 48.54 Billion 28.34 Billion 27.36 Billion
Cash And Short Term Investments 18.75 Billion 13.27 Billion 30.97 Billion 26.26 Billion 11.19 Billion 8.49 Billion
Cash and Cash Equivalents 18.75 Billion 13.27 Billion 30.73 Billion 26.26 Billion 10.97 Billion 7.83 Billion
Short Term Investments - -576 Million 244 Million -522 Million 220 Million 661 Million
Net Receivables 14.93 Billion 11.13 Billion 15.58 Billion 8.18 Billion 7.97 Billion 8.83 Billion
Inventory 20.93 Billion 18.51 Billion 14.63 Billion 13.55 Billion 8.85 Billion 9.11 Billion
Other Current Assets 2.95 Billion 4.87 Billion 990 Million 548 Million 317 Million 919 Million
Total Non-Current Assets 44.64 Billion 47.13 Billion 34.94 Billion 25.23 Billion 19.43 Billion 15.14 Billion
Net PPE 30.04 Billion 32.68 Billion 26.78 Billion 17.17 Billion 14.87 Billion 11.06 Billion
Good Will And Intangible Assets 3.49 Billion 3.65 Billion 2.96 Billion 3.23 Billion 263 Million 110 Million
Good Will - - - - - -
Intangible Assets 3.49 Billion 3.65 Billion 2.96 Billion 3.23 Billion 263 Million 110 Million
Long-Term Investments 9.12 Billion 9.44 Billion 2.76 Billion 3.09 Billion 3.57 Billion 3.59 Billion
Tax Assets 1.28 Billion 1.35 Billion 2.43 Billion 1.73 Billion 721 Million 378 Million
Other Non Current Assets 701 Million - - -1 Million -2 Million -
Other Assets - 2 Million 2 Million 3 Million 3 Million 2 Million
Total Liabilities 45.74 Billion 42.52 Billion 46.04 Billion 35.23 Billion 15.19 Billion 11.64 Billion
Total Current Liabilities 30.13 Billion 35.76 Billion 42.05 Billion 29.02 Billion 10.43 Billion 8.68 Billion
Account Payables 890 Million 1.56 Billion 1.32 Billion 2.93 Billion 679 Million 586 Million
Tax Payables 1.65 Billion 33 Million 5.91 Billion 2.64 Billion 534 Million 801 Million
Short Term Debt 8.95 Billion 17.3 Billion 15.15 Billion 12.85 Billion 4.92 Billion 3.8 Billion
Deferred Revenue 1.65 Billion 3.92 Billion 12.1 Billion 3.55 Billion 4.17 Billion 1.54 Billion
Other Current Liabilities 18.63 Billion 12.97 Billion 13.47 Billion 9.68 Billion 651 Million 2.74 Billion
Total Non Current Liabilities 15.61 Billion 6.76 Billion 3.99 Billion 6.2 Billion 4.76 Billion 2.96 Billion
Long-Term Debt 14.35 Billion 5.5 Billion 2.95 Billion 5.25 Billion 3.83 Billion 1.92 Billion
Deferred Revenue Non Current -441 Million -428 Million -343 Million -378 Million -343 Million -440 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 1.26 Billion 1.26 Billion 1.04 Billion 953 Million 932 Million 1.03 Billion
Other Liabilities - - - - - -
Total Equity 56.47 Billion 52.41 Billion 51.08 Billion 38.55 Billion 32.57 Billion 30.87 Billion
Stock Holders Equity 56.17 Billion 52.16 Billion 50.88 Billion 38.37 Billion 32.38 Billion 30.68 Billion
Common Stock 9.06 Billion 9.06 Billion 9.06 Billion 9.06 Billion 9.06 Billion 9.06 Billion
Retained Earnings 37.27 Billion 34.27 Billion 33.24 Billion 20.9 Billion 15.03 Billion 13.35 Billion
Accumulated other comprehensive income 2.41 Billion 1.42 Billion 1.18 Billion 1.15 Billion 1.26 Billion 1.28 Billion
Common Stock Equity 56.17 Billion 52.16 Billion 50.88 Billion 38.37 Billion 32.38 Billion 30.68 Billion
Capital Lease Obligation 82 Million 73 Million 44 Million 42 Million 77 Million 251 Million
Total Investments 9.12 Billion 8.86 Billion 2.23 Billion 2.57 Billion 2.4 Billion 2.94 Billion
Total Debt 23.3 Billion 22.8 Billion 18.1 Billion 18.1 Billion 8.75 Billion 5.73 Billion
Net Debt 4.54 Billion 9.52 Billion -12.63 Billion -8.16 Billion -2.21 Billion -2.1 Billion

Balance Sheet Charts